Medtronic, Inc.
Medtronic, Inc., a global leader in medical technology, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1949, the company has achieved significant milestones, including pioneering innovations in cardiac devices and diabetes management. Medtronic's core offerings encompass a wide range of products, such as insulin pumps, pacemakers, and surgical equipment, distinguished by their advanced technology and commitment to improving patient outcomes. With a strong market position, Medtronic is recognised for its contributions to minimally invasive therapies and chronic disease management. The company’s dedication to research and development has solidified its reputation as a trusted provider in the healthcare industry, making it a vital player in enhancing the quality of life for patients worldwide.
DitchCarbon Score
How does Medtronic, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medtronic, Inc.'s score of 45 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medtronic, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Medtronic plc, which influences its climate commitments and emissions reporting. As part of its climate strategy, Medtronic plc has set various reduction initiatives, although specific targets or achievements for Medtronic, Inc. are not detailed. The emissions data and climate initiatives are cascaded from Medtronic plc, which is responsible for the overarching sustainability goals and reporting. Medtronic plc is engaged in several industry-standard climate initiatives, including the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which guide its emissions reduction strategies. However, specific reduction targets for Medtronic, Inc. have not been disclosed. In summary, while Medtronic, Inc. inherits its climate commitments and emissions data from Medtronic plc, detailed emissions figures and specific reduction targets remain unspecified at this time.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 74,992,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 2 | 269,008,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medtronic, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
